Source: Frontiers in Immunology. Unidades: ICB, FM
Subjects: IMUNOLOGIA, ADENOVÍRUS, APOPTOSE, MELANOMA, IMUNOGENÉTICA, ONCOGENES, IMUNOTERAPIA, INTERFERONS, TRANSFERÊNCIA DE GENES, CAMUNDONGOS, CÉLULAS CULTIVADAS DE TUMOR, CÉLULAS DENDRÍTICAS
ABNT
CERQUEIRA, Otto Luiz Dutra et al. Combined p14ARF and interferon-β gene transfer to the human melanoma cell line SK-MEL-147 promotes oncolysis and immune activation. Frontiers in Immunology, v. 11, p. 13 , 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2020.576658. Acesso em: 31 ago. 2024.APA
Cerqueira, O. L. D., Salomon, M. A. C., Cardoso, E. C., Tortelli Junior, T. C., Mendonça, S. A., Barbuto, J. A. M., & Strauss, B. E. (2020). Combined p14ARF and interferon-β gene transfer to the human melanoma cell line SK-MEL-147 promotes oncolysis and immune activation. Frontiers in Immunology, 11, 13 . doi:10.3389/fimmu.2020.576658NLM
Cerqueira OLD, Salomon MAC, Cardoso EC, Tortelli Junior TC, Mendonça SA, Barbuto JAM, Strauss BE. Combined p14ARF and interferon-β gene transfer to the human melanoma cell line SK-MEL-147 promotes oncolysis and immune activation [Internet]. Frontiers in Immunology. 2020 ; 11 13 .[citado 2024 ago. 31 ] Available from: https://doi.org/10.3389/fimmu.2020.576658Vancouver
Cerqueira OLD, Salomon MAC, Cardoso EC, Tortelli Junior TC, Mendonça SA, Barbuto JAM, Strauss BE. Combined p14ARF and interferon-β gene transfer to the human melanoma cell line SK-MEL-147 promotes oncolysis and immune activation [Internet]. Frontiers in Immunology. 2020 ; 11 13 .[citado 2024 ago. 31 ] Available from: https://doi.org/10.3389/fimmu.2020.576658